MFS
FPRX

MSI Financial Services’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

MSI Financial Services’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$30K Buy
600
+587
+4,515% +$30.8K ﹤0.01% 2165
2016
Q3 		$1K Buy
+13
New +$621 ﹤0.01% 3789

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's FPRX Position: Q4 2016 in Review

MSI Financial Services increased its Five Prime Therapeutics, Inc. (FPRX) stake by 4,515% in Q4 2016, buying an estimated $30.8K and bringing the position to 600 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

MSI Financial Services first reported a position in FPRX in Q3 2016 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold FPRX as of Q4 2016.

  • MSI Financial Services held 600 shares of Five Prime Therapeutics, Inc. worth $30K as of Q4 2016.
  • MSI Financial Services bought 587 Five Prime Therapeutics, Inc. shares in Q4 2016, an estimated $30.8K.
  • Five Prime Therapeutics, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2165 holding.
  • MSI Financial Services first reported a position in Five Prime Therapeutics, Inc. in Q3 2016 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.